Search

Your search keyword '"Ionescu, Filip"' showing total 186 results
Start Over Author "Ionescu, Filip"
186 results on '"Ionescu, Filip"'

1. Feasibility of a Smartphone Application for Education and Symptom Management of Patients With Renal Cell Carcinoma on Combined Tyrosine Kinase and Immune Checkpoint Inhibitors

Author

Roman Souza, Gabriel, Turner, Kea, Gullapalli, Keerthi, Paravathaneni, Mahati, Ionescu, Filip, Semaan, Adele, DeJesus, Amayla Budet, Trujillo, Gillian, Le, Casey, Kim, Youngchul, Sun, Xiaoqi, Raymond, Sarah, Schneider, Amy, Manley, Brandon, Jain, Rohit, Gilbert, Scott, Jim, Heather S.L., Spiess, Philippe E., and Chahoud, Jad

Published
2024
Full Text
View/download PDF

3. Static Respiratory System Compliance as a Predictor of Extubation Failure in Patients with Acute Respiratory Failure

Author

Abplanalp, Lauren A., Ionescu, Filip, Calvo-Ayala, Enrique, Yu, Limin, and Nair, Girish B.

Subjects
Medical research -- Analysis, Medicine, Experimental -- Analysis, Respiratory insufficiency -- Research -- Prognosis -- Care and treatment, Patient compliance -- Analysis -- Research, Acute respiratory distress syndrome -- Research -- Care and treatment -- Prognosis, African Americans -- Analysis -- Research, Health
Abstract

Purpose Ventilator weaning protocols rely in part on objective indices to best predict extubation failure in the critically ill. We investigated static respiratory system compliance (RC) as a predictor of extubation failure, in comparison to extubation readiness using rapid shallow breathing index (RSBI). Material and Methods This was a cross-sectional, multi-institutional study of mechanically ventilated patients admitted between 12/01/2017 and 12/01/2019. All patients older than 18 years with a documented spontaneous breathing trial and extubation trial were included. RC and RSBI were calculated prior to the extubation trial. The primary outcome was extubation failure-defined as need for reintubation within 72 h from time of extubation. Results Of the 2263 patients, 55.8% were males with a mean age of 68 years. The population consisted mostly of Caucasians (73%) and African Americans (20.4%). 274 (12.1%) patients required reintubation within 72 h. On multivariate logistic regression after adjusting for age, sex, body mass index (BMI), admission Sequential Organ Failure Assessment (SOFA) score, number of ventilator days, and the P/F ratio on the day of extubation, RC remained the strongest predictor for extubation failure at 24 h (aOR 1.45; 95% CI 1.00-2.10) and 72 h (aOR 1.58; 95% CI 1.15-2.17). There was no significant association between RSBI and extubation failure at 24 (aOR 1.00; 95% CI 0.99-1.01) or at 72 h (aOR 1.00; 95% CI 0.99-1.01). Conclusion RC measured on the day of extubation is a promising physiological discriminant to potentially risk stratify patients with acute respiratory failure for extubation readiness. We recommend further validation studies in prospective cohorts., Author(s): Lauren A. Abplanalp [sup.1] [sup.2], Filip Ionescu [sup.2] [sup.4], Enrique Calvo-Ayala [sup.1] [sup.2], Limin Yu [sup.3], Girish B. Nair [sup.1] [sup.2] Author Affiliations: (1) grid.461921.9, 0000 0004 0460 1081, [...]

Published
2023
Full Text
View/download PDF

6. Evidence showing lipotoxicity worsens outcomes in covid-19 patients and insights about the underlying mechanisms

Author

Cartin-Ceba, Rodrigo, Khatua, Biswajit, El-Kurdi, Bara, Trivedi, Shubham, Kostenko, Sergiy, Imam, Zaid, Smith, Ryan, Snozek, Christine, Navina, Sarah, Sharma, Vijeta, McFayden, Bryce, Ionescu, Filip, Stolow, Eugene, Keiser, Sylvia, Tejani, Aziz, Harrington, Allison, Acosta, Phillip, Kuwelker, Saatchi, Echavarria, Juan, Nair, Girish B., Bataineh, Adam, and Singh, Vijay P.

Published
2022
Full Text
View/download PDF

8. Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study.

Author

Rose, Kyle M, Pham, Rachel, Zacharias, Niki M, Ionescu, Filip, Paravathaneni, Mahati, Marchetti, Kathryn A, Sanchez, Darren, Mustasam, Arfa, Sandstrom, Reagan, Vikram, Raghu, Dhillon, Jasreman, Rao, Priya, Schneider, Amy, Pagliaro, Lance, Alifrangis, Constantine, Albersen, Maarten, Roussel, Eduard, Master, Viraj A, Nazha, Bassel, and Hernandez, Cindy

Subjects
PENILE cancer, NEOADJUVANT chemotherapy, PATHOLOGIC complete response, PROGRESSION-free survival, LYMPHADENECTOMY, SQUAMOUS cell carcinoma
Abstract

Introduction This study investigated the efficacy and safety of neoadjuvant chemotherapy for locally advance penile squamous cell carcinoma for which current evidence is lacking. Methods Included patients had locally advanced penile squamous cell carcinoma with clinical lymph node metastasis treated with at least 1 dose of neoadjuvant chemotherapy prior to planned consolidative lymphadenectomy. Objective response rates were assessed using Response Evaluation Criteria in Solid Tumors v1.1. The primary and secondary outcomes were overall survival and progression-free survival, estimated by the Kaplan–Meier method. Treatment-related adverse events were graded per the Common Terminology Criteria for Adverse Events v5.0. Results A total of 209 patients received neoadjuvant chemotherapy for locally advanced and clinically node-positive penile squamous cell carcinoma. The study population consisted of 7% of patients with stage II disease, 48% with stage III, and 45% with stage IV. Grade 2 treatment-related adverse events occurred in 35 (17%) patients, and no treatment-related mortality was observed. Of the patients, 201 (97%) completed planned consolidative lymphadenectomy. During follow-up, 106 (52.7%) patients expired, with a median overall survival of 37.0 months (95% confidence interval [CI] = 23.8 to 50.1 months) and median progression-free survival of 26.0 months (95% CI = 11.7 to 40.2 months). Objective response rate was 57.2%, with 87 (43.2%) having partial response and 28 (13.9%) having a complete response. Patients with objective response to neoadjuvant chemotherapy had a longer median overall survival (73.0 vs 17.0 months, P  < .01) compared with those who did not. The lymph node pathologic complete response rate was 24.8% in the cohort. Conclusion Neoadjuvant chemotherapy with lymphadenectomy for locally advanced penile squamous cell carcinoma is well tolerated and active to reduce the disease burden and improve long-term survival outcomes. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Fludarabine Lymphodepletion Exposure Is Associated with Idecabtagene Vicleucel Toxicity in Relapsed and Refractory Multiple Myeloma Patients: Real-World Experience from the US Myeloma Immunotherapy Consortium

Author

Wagner, Charlotte B, primary, Sweiss, Karen, additional, Anto, Eric, additional, Gonzalez, Rebecca, additional, Castaneda Puglianini, Omar Alexis, additional, Freeman, Ciara Louise L., additional, Ionescu, Filip, additional, Patel, Krina K., additional, Ferreri, Christopher, additional, Gaballa, Mahmoud, additional, Shune, Leyla, additional, McGuirk, Joseph P, additional, Sidana, Surbhi, additional, Hovanky, Vanna, additional, Khouri, Jack, additional, Dima, Danai, additional, Hashmi, Hamza, additional, Davis, James A, additional, Afrough, Aimaz, additional, Kaur, Gurbakhash, additional, Anderson, Larry D., additional, Forsberg, Peter A., additional, Herr, Megan, additional, Hansen, Doris K., additional, Sborov, Douglas, additional, and Kocoglu, Mehmet H., additional

Published
2023
Full Text
View/download PDF

11. The Prognostic Role of Human Papillomavirus and p16 Status in Penile Squamous Cell Carcinoma—A Systematic Review

Author

Parza, Kevin, primary, Mustasam, Arfa, additional, Ionescu, Filip, additional, Paravathaneni, Mahati, additional, Sandstrom, Reagan, additional, Safa, Houssein, additional, Grass, G. Daniel, additional, Johnstone, Peter A., additional, Eschrich, Steven A., additional, Chadha, Juskaran, additional, Zacharias, Niki, additional, Pettaway, Curtis A., additional, Spiess, Philippe E., additional, and Chahoud, Jad, additional

Published
2023
Full Text
View/download PDF

12. Alterations in tumor immune microenvironment and progressive immune exhaustion with advancing penile squamous cell carcinoma using multiplex immunofluorescence and image analysis.

Author

Gullapalli, Keerthi, Ionescu, Filip, Roman Souza, Gabriel, Paravathaneni, Mahati, Eschrich, Steven A., Kim, Youngchul, Whiting, Junmin, Grass, G. Daniel, Jain, Rohit K., Segura, Carlos Moran, Nguyen, Jonathan, Yu, Alice, Zemp, Logan, Spiess, Philippe E., and Chahoud, Jad

Published
2024
Full Text
View/download PDF

13. The feasibility of an educational and monitoring smartphone application for patients with advanced renal cell carcinoma undergoing combination immunotherapy.

Author

Roman Souza, Gabriel, Paravathaneni, Mahati, Ionescu, Filip, Gullapalli, Keerthi, Raymond, Sarah, Jameel, Ghazal, Chadha, Juskaran, Jain, Rohit K., Trujillo, Gillian, Budet DeJesus, Amayla M., Manley, Brandon J., Schneider, Amy, Kim, Youngchul, Semaan, Adele, Jim, Heather S.L., Spiess, Philippe E., and Chahoud, Jad

Published
2024
Full Text
View/download PDF

14. Multiplex Immunofluorescence Captures Progressive Immune Exhaustion with Advancing Penile Squamous Cell Cancer Stage.

Author

Ionescu, Filip, Nguyen, Jonathan, Segura, Carlos Moran, Paravathaneni, Mahati, Grass, G. Daniel, Johnstone, Peter, Zacharias, Niki M., Pettaway, Curtis A., Lu, Xin, Kim, Youngchul, Whiting, Junmin, Dhillon, Jasreman, Eschrich, Steven A., Chadha, Juskaran, Gullapalli, Keerthi, Roman Souza, Gabriel, Miyagi, Hiroko, Manley, Brandon J., Spiess, Philippe E., and Chahoud, Jad

Subjects
*IMMUNOLOGICAL tolerance, *DISEASE progression, *BIOCHEMISTRY, *PENILE tumors, *IMMUNE checkpoint inhibitors, *PHENOMENOLOGICAL biology, *CYTOMETRY, *MACROPHAGES, *CELL physiology, *TUMOR classification, *CANCER patients, *FLUORESCENT antibody technique, *PAPILLOMAVIRUS diseases, *DESCRIPTIVE statistics, *SQUAMOUS cell carcinoma
Abstract

Simple Summary: Penile cancer is a rare and aggressive disease. Current treatment options when the cancer is locally advanced are suboptimal and potentially mutilating. Insight into the immune dysregulation necessary for the emergence of penile cancer could suggest innovative ways to manipulate the immune system which have already demonstrated efficacy in other, more common malignancies. In this paper, we use multiplex immunofluorescence, a novel technology, to investigate the immune microenvironment of penile cancer for the first time. We describe a pattern of immune exhaustion as cancer becomes more advanced and identify tumor-associated macrophages as a potential key player in regulating this process. Penile squamous cell carcinoma (PSCC) is a rare and deadly malignancy. Therapeutic advances have been stifled by a poor understanding of disease biology. Specifically, the immune microenvironment is an underexplored component in PSCC and the activity of immune checkpoint inhibitors observed in a subset of patients suggests immune escape may play an important role in tumorigenesis. Herein, we explored for the first time the immune microenvironment of 57 men with PSCC and how it varies with the presence of human papillomavirus (HPV) infection and across tumor stages using multiplex immunofluorescence of key immune cell markers. We observed an increase in the density of immune effector cells in node-negative tumors and a progressive rise in inhibitory immune players such as type 2 macrophages and upregulation of the PD-L1 checkpoint in men with N1 and N2-3 disease. There were no differences in immune cell densities with HPV status. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

16. Fludarabine Exposure Impact on Safety and Efficacy of Idecabtagene Vicleucel in Relapsed/Refractory Multiple Myeloma (RRMM)

Author

Ionescu, Filip, primary, Freeman, Ciara, additional, Castaneda, Omar, additional, Blue, Brandon Jamaal, additional, Grajales, Ariel, additional, Powell, Cole T., additional, De Avila, Gabe, additional, Peres, Lauren, additional, Oswald, Laura, additional, Ochoa, Leonel, additional, Shrewsbury, Alexandria M, additional, Harvey, Kristy, additional, Quealy, Catherine, additional, Bachmeier, Christina A, additional, Gonzalez, Rebecca, additional, Logue, Jennifer, additional, Faramand, Rawan G, additional, Elmariah, Hany, additional, Jain, Michael D, additional, Liu, Hien, additional, Brayer, Jason, additional, Nishihori, Taiga, additional, Shain, Kenneth, additional, Baz, Rachid, additional, Alsina, Melissa, additional, Locke, Frederick L., additional, Altrock, Philipp M, additional, and Hansen, Doris K, additional

Published
2023
Full Text
View/download PDF

17. Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience

Author

Ionescu, Filip, primary, Ajayi, Eloho, additional, Leach, Aamia, additional, Alsina, Melissa, additional, Bejanyan, Nelli, additional, Castaneda, Omar, additional, Elmariah, Hany, additional, Freeman, Ciara, additional, Hansen, Doris K, additional, Jain, Michael D, additional, Khimani, Farhad, additional, Lazaryan, Aleksandr, additional, Liu, Hien, additional, Locke, Frederick L., additional, Mishra, Asmita, additional, Nieder, Dr. Michael L., additional, Ochoa, Leonel, additional, Perez, Lia Elena, additional, Pidala, Joseph A., additional, Quilitz, Rod, additional, Klinkova, Olga V, additional, Baluch, Aliyah, additional, Nishihori, Taiga, additional, and Faramand, Rawan G, additional

Published
2023
Full Text
View/download PDF

18. The Prognostic Role of Human Papillomavirus and p16INK4a Status in Penile Squamous Cell Carcinoma: A Meta-Analysis

Author

Mustasam, Arfa, primary, Parza, Kevin, additional, Ionescu, Filip, additional, Gullapalli, Keerthi, additional, Paravathaneni, Mahati, additional, Kim, Youngchul, additional, Sandstrom, Reagan E., additional, Grass, G. Daniel, additional, Johnstone, Peter, additional, Eschrich, Steven, additional, Safa, Houssein, additional, Chadha, Juskaran, additional, Souza, Gabriel Roman, additional, David, Jarel, additional, Semaan, Adele, additional, Zacharias, Nikki M., additional, Pettaway, Curtis A., additional, Giuliano, Anna, additional, Spiess, Philippe E., additional, and Chahoud, Jad, additional

Published
2023
Full Text
View/download PDF

19. Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience

Author

Ionescu, Filip, primary, Ajayi, Eloho, additional, Leach, Aamia, additional, Alsina, Melissa, additional, Bejanyan, Nelli, additional, Castaneda-Puglianini, Omar, additional, Elmariah, Hany, additional, Freeman, Ciara L., additional, Hansen, Doris K., additional, Jain, Michael D., additional, Khimani, Farhad, additional, Lazaryan, Aleksandr, additional, Liu, Hien D., additional, Locke, Frederick L., additional, McIver, Bryan, additional, Mishra, Asmita, additional, Nieder, Michael, additional, Ochoa, Jose, additional, Perez, Lia, additional, Pidala, Joseph, additional, Baluch, Aliyah, additional, Klinkova, Olga, additional, Quilitz, Rod, additional, Nishihori, Taiga, additional, and Faramand, Rawan, additional

Published
2022
Full Text
View/download PDF

20. Outcomes of Acute Myeloid Leukemia Relapsed Post-Allogeneic Hematopoietic Stem Cell Transplant Treated with Hypomethylating Agents and Venetoclax Combination: A Single Center Experience

Author

Ionescu, Filip, primary, Sallman, David A., additional, Sweet, Kendra, additional, Komrokji, Rami S., additional, Chan, Onyee, additional, Kuykendall, Andrew, additional, Padron, Eric, additional, Faramand, Rawan, additional, Bejanyan, Nelli, additional, Khimani, Farhad, additional, Elmariah, Hany, additional, Pidala, Joseph, additional, Mishra, Asmita, additional, Perez, Lia, additional, Nishihori, Taiga, additional, and Lancet, Jeffrey E., additional

Published
2022
Full Text
View/download PDF

22. A Phase 1b Adaptive Androgen Deprivation Therapy Trial in Metastatic Castration Sensitive Prostate Cancer

Author

Zhang, Jingsong, primary, Gallaher, Jill, additional, Cunningham, Jessica J., additional, Choi, Jung W., additional, Ionescu, Filip, additional, Chatwal, Monica S., additional, Jain, Rohit, additional, Kim, Youngchul, additional, Wang, Liang, additional, Brown, Joel S., additional, Anderson, Alexander R., additional, and Gatenby, Robert A., additional

Published
2022
Full Text
View/download PDF

25. A Phase 1b Adaptive Androgen Deprivation Therapy Trial in Metastatic Castration Sensitive Prostate Cancer

Author

Zhang, Jingsong, Gallaher, Jill, Cunningham, Jessica J., Choi, Jung W., Ionescu, Filip, Chatwal, Monica S., Jain, Rohit, Kim, Youngchul, Wang, Liang, Brown, Joel S., Anderson, Alexander R., Gatenby, Robert A., Zhang, Jingsong, Gallaher, Jill, Cunningham, Jessica J., Choi, Jung W., Ionescu, Filip, Chatwal, Monica S., Jain, Rohit, Kim, Youngchul, Wang, Liang, Brown, Joel S., Anderson, Alexander R., and Gatenby, Robert A.

Abstract

Simple Summary Despite early utilization of new hormonal agents (NHA, i.e., abiraterone, enzalutamide and apalutamide) for combined androgen deprivation therapy (ADT) for metastatic prostate cancer, increasingly more men are dying from this disease. While continued development of new drugs is needed, we propose that improved survival of metastatic prostate cancer can be obtained through evolutionarily informed treatment strategies that adjust patient-specific-dosing to their current and past Prostate Specific Antigen (PSA) levels. Compared to the conventional treat-until-progression paradigm, our previous study in metastatic castration resistant prostate cancer (NCT02415621) showed that an on-and-off abiraterone therapy adapted to an individual's PSA response dynamics provided better cancer control with less drug usage. Here, we report the feasibility of applying this strategy to newly diagnosed metastatic prostate cancer. On-and-off ADTs with luteinizing hormone releasing hormone (LHRH) analog, an NHA, or in combination were based on individual's testosterone and PSA levels. The current study represents the foundation for future efforts to validate our adaptive therapy in randomized controlled studies for metastatic prostate cancer. Background: We hypothesize that cancer survival can be improved through adapting treatment strategies to cancer evolutionary dynamics and conducted a phase 1b study in metastatic castration sensitive prostate cancer (mCSPC). Methods: Men with asymptomatic mCSPC were enrolled and proceeded with a treatment break after achieving > 75% PSA decline with LHRH analog plus an NHA. ADT was restarted at the time of PSA or radiographic progression and held again after achieving >50% PSA decline. This on-off cycling of ADT continued until on treatment imaging progression. Results: At data cut off in August 2022, only 2 of the 16 evaluable patients were off study due to imaging progression at 28 months from first dose of LHRH analog for mCSPC. Two

Published
2022

30. Second-Line Chimeric Antigen Receptor T Cell Therapy (CAR-T) As Standard of Care for Relapsed-Refractory Large B-Cell Lymphoma (LBCL)

Author

Dahiya, Saurabh, Spiegel, Jay Y., Lee, Dasom, Mohammed, Turab, Lutfi, Forat, Goyal, Anmol, Hana, Caroline, Chavez, Julio C, Ionescu, Filip, Frank, Matthew J., Bharadwaj, Sushma, Sandoval-Sus, Jose, Beitinjaneh, Amer M., Lekakis, Lazaros J., McGuirk, Joseph P, Locke, Frederick L., Miklos, David B., and Jain, Michael D.

Published
2023
Full Text
View/download PDF

32. Cladribine and Cyclophosphamide Lymphodepletion Prior to Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma

Author

Ionescu, Filip, Shah, Bijal D., Menges, Meghan, Reid, Kayla, Bailey, Hanna, DiMaggio, Elizabeth, Gonzalez, Rebecca, Bachmeier, Christina A, Corallo, Salvatore, Cuadrado Delgado, Luis, Mohammed, Turab, Nishihori, Taiga, Khimani, Farhad, Lazaryan, Aleksandr, Liu, Hien, Davila, Marco, Perna, Fabiana, Chavez, Julio C, Locke, Frederick L., and Jain, Michael D.

Published
2023
Full Text
View/download PDF

33. Poor Hematopoietic Reserve at the Time of CD19 CAR T-Cell Infusion Is Associated with Long Term B-Cell Aplasia

Author

Johnson, Grace, Patel, Kedar, Arciola, Brian, Perez Perez, Ariel, Wood, Anthony, Ionescu, Filip, Logue, Jennifer M, Albanyan, Omar, Yasin, Hassaan, Bachmeier, Christina A, Reid, Kayla, Menges, Meghan, Corallo, Salvatore, Shah, Bijal D., Chavez, Julio C, Khimani, Farhad, Nishihori, Taiga, Faramand, Rawan, Liu, Hien, Lazaryan, Aleksandr, Rejeski, Kai, Subklewe, Marion, Perna, Fabiana, Davila, Marco, Mhaskar, Rahul, Locke, Frederick L., and Jain, Michael D.

Published
2023
Full Text
View/download PDF

37. 437 - Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience

Author

Ionescu, Filip, Ajayi, Eloho, Leach, Aamia, Alsina, Melissa, Bejanyan, Nelli, Castaneda, Omar, Elmariah, Hany, Freeman, Ciara, Hansen, Doris K, Jain, Michael D, Khimani, Farhad, Lazaryan, Aleksandr, Liu, Hien, Locke, Frederick L., Mishra, Asmita, Nieder, Dr. Michael L., Ochoa, Leonel, Perez, Lia Elena, Pidala, Joseph A., Quilitz, Rod, Klinkova, Olga V, Baluch, Aliyah, Nishihori, Taiga, and Faramand, Rawan G

Published
2023
Full Text
View/download PDF

38. 245 - Fludarabine Exposure Impact on Safety and Efficacy of Idecabtagene Vicleucel in Relapsed/Refractory Multiple Myeloma (RRMM)

Author

Ionescu, Filip, Freeman, Ciara, Castaneda, Omar, Blue, Brandon Jamaal, Grajales, Ariel, Powell, Cole T., De Avila, Gabe, Peres, Lauren, Oswald, Laura, Ochoa, Leonel, Shrewsbury, Alexandria M, Harvey, Kristy, Quealy, Catherine, Bachmeier, Christina A, Gonzalez, Rebecca, Logue, Jennifer, Faramand, Rawan G, Elmariah, Hany, Jain, Michael D, Liu, Hien, Brayer, Jason, Nishihori, Taiga, Shain, Kenneth, Baz, Rachid, Alsina, Melissa, Locke, Frederick L., Altrock, Philipp M, and Hansen, Doris K

Published
2023
Full Text
View/download PDF

39. Increasing Doses of Anticoagulation Are Associated with Improved Survival in Hospitalized COVID-19 Patients

Author

Ionescu, Filip, primary, Nair, Girish B, additional, Petrescu, Ioana, additional, Konde, Anish S, additional, Zimmer, Markie Sue, additional, Anusim, Nwabundo, additional, Jindal, Vishal, additional, Gaikazian, Susanna, additional, Anderson, Joseph, additional, Stender, Michael, additional, Huben, Marianne Terese, additional, and Jaiyesimi, Ishmael, additional

Published
2020
Full Text
View/download PDF

40. Association of anticoagulation dose and survival in hospitalized COVID‐19 patients: A retrospective propensity score‐weighted analysis

Author

Ionescu, Filip, primary, Jaiyesimi, Ishmael, additional, Petrescu, Ioana, additional, Lawler, Patrick R, additional, Castillo, Edward, additional, Munoz‐Maldonado, Yolanda, additional, Imam, Zaid, additional, Narasimhan, Mangala, additional, Abbas, Amr E., additional, Konde, Anish, additional, and Nair, Girish B., additional

Published
2020
Full Text
View/download PDF

42. BIO-MECHANICS OF ARDS IN COVID-19: A PROSPECTIVE OBSERVATIONAL STUDY

Author

Naeem, Ehsun, primary, Ionescu, Filip, additional, Imam, Zaid, additional, Castillo, Edward, additional, Ayala, Enrique Calvo, additional, Dogra, Sanjay, additional, Patel, Vishal, additional, Mina, Nader, additional, Keena, Daniel, additional, Dalal, Bhavinkumar, additional, Dado, Christopher, additional, Adam, Abdulgadir, additional, Grasso-Knight, Giovi, additional, Bozyk, Paul, additional, and Nair, Girish, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results